OWLT
Owlet, Inc.
NYSE · USHealthcareMedical - Devices
$5.64+0.71%
Price as of Jul 20, 2026
OWLT financials
Owlet, Inc. financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $105.7M | $78.1M | $54.0M | $69.2M |
| Cost of revenue | $52.2M | $38.7M | $31.4M | $45.9M |
| Gross profit | $53.5M | $39.3M | $22.6M | $23.3M |
| Operating expenses | $61.8M | $59.5M | $51.2M | $107.9M |
| Operating income | -$8.3M | -$20.2M | -$28.6M | -$84.6M |
| Net income | -$39.7M | -$12.5M | -$32.9M | -$79.3M |
| EBITDA | -$35.6M | -$9.5M | -$27.5M | -$75.5M |
| Basic EPS | $-2.24 | $-0.83 | $-4.53 | $-9.97 |
| Diluted EPS | $-2.24 | $-0.83 | $-4.53 | $-9.97 |
| Balance sheet | ||||
| Cash & equivalents | $35.5M | $20.2M | $16.6M | $11.2M |
| Total assets | $85.6M | $49.5M | $44.1M | $58.1M |
| Total liabilities | $50.2M | $70.7M | $73.8M | $68.7M |
| Stockholders’ equity | $35.4M | -$21.1M | -$29.7M | -$10.6M |
| Total debt | $13.0M | $11.9M | $16.4M | $18.3M |
| Net debt | -$22.5M | -$8.4M | -$172.0K | $7.1M |
| Cash flow | ||||
| Operating cash flow | -$10.8M | -$11.2M | -$23.5M | -$81.4M |
| Capital expenditure | -$273.0K | -$761.0K | -$59.0K | -$1.6M |
| Free cash flow | -$11.1M | -$12.0M | -$23.6M | -$82.9M |
| Dividends paid | $0.00 | $0.00 | $0.00 | $0.00 |
| Share repurchases | $0.00 | $0.00 | $0.00 | $0.00 |